Pall Acquires Molecular Diagnostics Manufacturer GeneSystems

Article

Pall Corporation (East Hills, NY) has purchased GeneSystems (Bruz, France), a privately held biotechnology company that has developed a molecular diagnostics platform.

Pall Corporation (East Hills, NY) has purchased GeneSystems (Bruz, France), a privately held biotechnology company that has developed a molecular diagnostics platform.

The acquisition of GeneSystems, with its patented approach to rapid microbiological detection equipment and disposables, expands Pall’s Total Fluid Management (TFM) capabilities in the $1-billion biopharmaceuticals process monitoring market.

Process monitoring includes the analytical tests required during biopharmaceuticals manufacturing for environmental monitoring, in-process control testing, and finished product release testing. These tests are receiving increased regulatory scrutiny and support under initiatives such as process analytical technology (PAT).

Pall release

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.